Open AccessHow Can the Current Strategies forHelicobacter pyloriEradication Therapy be Improved?
Author(s) -
Alexander C. Ford,
Paul Moayyedi
Publication year - 2003
Publication title -
canadian journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
eISSN - 2291-2797
pISSN - 2291-2789
DOI - 10.1155/2003/714124
Subject(s) - lansoprazole , regimen , clarithromycin , proton pump inhibitor , omeprazole , medicine , metronidazole , rabeprazole , helicobacter pylori , amoxicillin , randomized controlled trial , relative risk , gastroenterology , confidence interval , antibiotics , biology , microbiology and biotechnology
The use of Helicobacter pylori eradication therapy is advocated in an increasing variety of situations. It is therefore important to optimise current strategies to eradicate H pylori infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom